Page last updated: 2024-12-08
histidinal
Description
L-histidinal : An amino aldehyde obtained by partial reduction of the carboxy group of L-histidine [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 152657 |
| CHEMBL ID | 307302 |
| CHEBI ID | 27676 |
| SCHEMBL ID | 234365 |
| MeSH ID | M0133993 |
Synonyms (23)
| Synonym |
|---|
| C01929 |
| HISTIDINAL , |
| l-histidinal |
| chebi:27676 , |
| CHEMBL307302 |
| (2s)-2-amino-3-(1h-imidazol-5-yl)propanal |
| 23784-15-8 |
| 2-amino-3-(1h-imidazol-5-yl)propanal |
| l-histidinaldehyde |
| 1h-imidazole-4-propanal, alpha-amino-, (s)- |
| j7g22ner35 , |
| histidinaldehyde |
| unii-j7g22ner35 |
| (2s)-2-amino-3-(1h-imidazol-4-yl)propanal |
| SCHEMBL234365 |
| Q27103256 |
| DTXSID10946581 |
| (s)-2-amino-3-(1h-imidazol-5-yl)propanal |
| cuprate(3-), 2-3-4-2-2-(ethenylsulfonyl)ethoxyethylamino-6-fluoro-1,3,5-triazin-2-ylamino-2-(hydroxy |
| 2-amino-3-(1h-imidazol-5-yl)propanal, (2s)- |
| 4-imidazolepropionaldehyde, alpha-amino-, l- |
| histidinal, l- |
| (alphas)-alpha-amino-1h-imidazole-5-propanal |
Drug Classes (2)
| Class | Description |
|---|
| amino aldehyde | Any aldehyde which contains an amino group. |
| imidazoles | A five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 17.67
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 17.67 (24.57) | | Research Supply Index | 2.08 (2.92) | | Research Growth Index | 4.56 (4.65) | | Search Engine Demand Index | 10.37 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |